This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
AstraZeneca has terminated all development of vemircopan, the oral factor D inhi...
We’re in dealmaking season for publicly traded digital health companies. In ...
Almost 16 years after Rituxan's disappointing data in lupus, Roche's Genentech f...
A trade group representing 1,600 hospitals says 340B rebate models proposed by m...
After promoting its oncology officer Chris Boshoff to chief scientific officer l...
Personify Health, which sells healthcare spending management services to employe...
Bristol Myers Squibb is ending work on a handful of assets, including an immunol...
After running into clinical hurdles with its “diamond in the rough” strategy, Lo...
Cystic fibrosis biotech Sionna Therapeutics will raise $191 million in its upsiz...
Novo Nordisk said Friday that its hemophilia A preventive Mim8 was effective in ...
→ Francisco Ballester is retiring as president, region international at Sandoz o...
The Mitsubishi Chemical Group is selling its centuries-old pharmaceutical busine...
The life science investment firm Bioluminescence Ventures will close its doors l...
A 66-year-old man whose kidneys were failing is now the fourth person who has re...
The Trump administration's reported plans to potentially lay off thousands of FD...